EYLEA Sales

Shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) were trading lower by around 7 percent early Tuesday morning after the company reported its fourth quarter results. Regeneron Pharmaceuticals said that it earned $2.83 per share in the fourth quarter on revenue of $1.16 billion. Wall Street...